Fibroblast heterogeneity in prostate carcinogenesis.

Sathyavathi ChallaSivaKanaka1, Renee E Vickman1, Mamatha Kakarla1

  • 1Department of Surgery, NorthShore University HealthSystem, Research Institute, 1001 University Place, Evanston, IL, 60201, USA.

Cancer Letters
|October 29, 2021
PubMed
Summary

Cancer-associated fibroblasts (CAFs) are key players in prostate cancer (PCa) progression, promoting growth and remodeling the tumor microenvironment. Understanding CAF heterogeneity is crucial for developing effective PCa treatments.